<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220507054759N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-26</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>The effectiveness of schema therapy on personality disorders (dependent disorder, obsessive-compulsive disorder) in middle-aged people.</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of schema therapy on c cluster personality disorders (dependent disorder, obsessive-compulsive disorder) in middle-aged people.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63396</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: In this study, out of 30 people, the sample size that we will study is 15 people in the control group and 15 people in the experimental group by simple random method, so that the names are not written and we put them in a container.  We put the remaining 15 names in the control group; in this method, each person has an equal chance with other people to be selected.  For the intervention group, we start schema therapy (Schema: maladaptive patterns that are formed as behaviors in the individual's relationships from childhood.)  We use techniques such as imaginative dialogue and mental visualization to modify schemas and coping styles, Randomization description: We randomly select the sample size from people who have referred to counseling centers in Arak and have the following conditions:
 Having cluster personality disorders c, being employed, living in Arak, middle-aged age group
 In this study, out of 30 people, the sample size that we will study is 15 people in the control group and 15 people in the experimental group by simple random method, so that the names are not written and we put them in a container.  We put the remaining 15 names in the control group; in this method, each person has an equal chance with other people to be selected.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Dependent personality disorder. Condition 2: Obsessive-compulsive disorder. Condition 3: Avoidant personality disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: There are 15 subjects in this group who are being treated. This treatment focuses on the individual's maladaptive schemas (schemas: deep and pervasive and repetitive patterns of behavior that have been formed since childhood) The number of sessions is ten sessions. In the first sessions, we introduce the members to each other and explain briefly and in simple language the schemas, how they are formed, the coping styles and the schema treatment in simple language, and in the next sessions we try. We have to find the schemas in the members. And after identifying with existing techniques such as imaginary dialogue, evaluating the advantages and disadvantages of schemas, teaching healthy adult reinforcement to individuals and establishing healthy communication. Intervention 2: Control group: There are 15 subjects in this group who are not treated.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Somye Saadat Esmati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University Arak Branch, 3rd km of Khomein road, Imam Khomeini Square , Arak, Iran</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3836119131</zip>
        <telephone>+98 86 3341 2101</telephone>
        <email>somaye.saadat1375@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ramin zare</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University Arak Branch, 3rd km of Khomein road, Imam Khomeini Square , Arak, Iran</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3836119131</zip>
        <telephone>+98 86 3341 2101</telephone>
        <email>r-zare@iau-arak.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Must be at least 30 years old and at most 45 years old
Be employed
Having dependent personality disorders
Having avoidant personality disorders
Having obsessive personality disorders
Resident of Arak city</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having a drug addiction
Do not be on medication
People with mental retardation
Having acute mental disorders</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F60.7</hc_code>
      <hc_code>F42</hc_code>
      <hc_code>F60.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Dependent personality disorder</hc_keyword>
      <hc_keyword>Obsessive-compulsive disorder</hc_keyword>
      <hc_keyword>Avoidant personality disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: There are 15 subjects in this group who are being treated. This treatment focuses on the individual's maladaptive schemas (schemas: deep and pervasive and repetitive patterns of behavior that have been formed since childhood) The number of sessions is ten sessions. In the first sessions, we introduce the members to each other and explain briefly and in simple language the schemas, how they are formed, the coping styles and the schema treatment in simple language, and in the next sessions we try. We have to find the schemas in the members. And after identifying with existing techniques such as imaginary dialogue, evaluating the advantages and disadvantages of schemas, teaching healthy adult reinforcement to individuals and establishing healthy communication.</i_keyword>
      <i_keyword>Control group: There are 15 subjects in this group who are not treated</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Dependent personality disorder. Timepoint: At the beginning of the study and one month later as the end of the study. Method of measurement: Millon Questionnaire.</prim_outcome>
      <prim_outcome>Obsessive-compulsive disorder. Timepoint: At the beginning of the study and one month later as the end of the study. Method of measurement: Millon Questionnaire.</prim_outcome>
      <prim_outcome>Avoidant personality disorder. Timepoint: At the beginning of the study and one month later as the end of the study. Method of measurement: Millon Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Azad University of Arak</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-12</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, Arak Branch</contact_name>
        <contact_address>Islamic Azad University Arak Branch, 3rd km of Khomein road, Imam Khomeini Square , Arak, Iran Arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
